The specific TLR4 inhibitor, TAK-242, significantly attenuated the severity of DSS-induced colitis in CK8+/− mice, suggesting that TLR4/NF-kB signaling may be involved in the inflammatory response to microbiota and may further promote tumor formation. Here, NFKB1 is linked to neoplasm.